Clinical use of positron emission tomography in tumor patients
Schober, O.; Meyer, G.J.
Zeitschrift für Gastroenterologie. Verhandlungsband 24: 152-154
1989
ISSN/ISBN: 0172-8504 PMID: 2474934 Document Number: 332691
Document emailed within 1 workday
Related Documents
Sakai, M.; Kato, H.; Saito, K.; Tanaka, N.; Inose, T.; Kimura, H.; Miyazaki, T.; Kuwano, H. 2008: Clinical applications of 18F-fluorodeoxyglucose positron emission tomography in gastrointestinal stromal tumor of the esophagus International Surgery 93(4): 209-213Tsai, M-Hsui.; Huang, W-Sheng.; Tsai, J.J.; Chen, Y-Kung.; Changlai, S-Pin.; Kao, C-Hung. 2003: Differentiating recurrent or residual nasopharyngeal carcinomas from post-radiotherapy changes with 18-fluoro-2-deoxyglucose positron emission tomography and thallium-201 single photon emission computed tomography in patients with indeterminate computed tomography findings Anticancer Research 23(4): 3513-3516
Kobayashi, N.; Fujita, K.; Fujisawa, T.; Takahashi, H.; Yoneda, M.; Abe, Y.; Inamori, M.; Kirikoshi, H.; Kubota, K.; Saito, S.; Nakajima, A. 2008: Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 65-70
Kjaer, A. 2005: Molecular imaging with positron emission tomography and single photon emission computer tomography. Status and perspectives Ugeskrift for Laeger 167(48): 4549-4552
Imahori, Y.; Sasajima, H.; Mineura, K.; Imahori, Y. 2005: Molecular imaging for brain tumor using positron emission tomography Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 250-257
Shen, Y.Y.; Su, C.T.; Chen, G.J.S.; Chen, Y.K.; Liao, A.C.F.; Tsai, F.S. 2003: The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening Neoplasma 50(3): 217-221
Wijsman, R.; Kaanders, J.H.; Oyen, W.J.; Bussink, J. 2013: Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(3): 244-256
Schipper, J.H.; Schrader, M.; Arweiler, D.; Müller, S.; Sciuk, J. 1996: Positron emission tomography for primary tumor detection in lymph node metastases with unknown primary tumor Hno 44(5): 254-257
Mazziotta, J.C. 1988: Practical clinical applications of positron emission tomography in epilepsy American Journal of Physiologic Imaging 3(1): 28-29
Schuhmacher, J.; Klivényi, G.; Matys, R.; Stadler, M.; Regiert, T.; Hauser, H.; Doll, J.; Maier-Borst, W.; Zöller, M. 1995: Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography Cancer Research 55(1): 115-123
Ueda, T.; Takagi, M. 2006: Cerebral hemodynamics and metabolism in patients with TIA using positron emission tomography Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 8): 297-302
Yiu, C.R.; Kao, Y.H.; Phipps, C.; Tan, D. 2011: Positron emission tomography findings in patients with lymphoma-associated haemophagocytic syndrome Singapore Medical Journal 52(7): e156-e159
Momose, T. 2004: Measurement of brain function by positron emission tomography--clinical application of PET to neurological disorders Rinsho Shinkeigaku 44(11): 897-899
Soepenberg, O. 2000: Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology Nederlands Tijdschrift Voor Geneeskunde 144(41): 1979-1980
De Leeuw, K.; Bijl, M.; Jager, P.L. 2004: Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides Clinical and Experimental Rheumatology 22(6 Suppl 36: S21-S26
Mautner, V.F.; Brenner, W.; Fünsterer, C.; Hagel, C.; Gawad, K.; Friedrich, R.E. 2007: Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1 Anticancer Research 27(4a): 1819-1822
Savicheva, I.I.; Kostenikov, N.A.; Fadeev, N.P.; Tiutin, L.A.; Savello, V.E.; Ryzhkova, D.V. 1999: Application of new radiopharmaceutical "Sodium 11c-butyrate" and positron emission tomography in patients with coronary artery disease Vestnik Rentgenologii i Radiologii 5: 18-21
Hägglund, J.; Aquilonius, S.M.; Bergström, K.; Eckernäs, S.A.; Hartvig, P.; Lundqvist, H.; Långström, B.; Malmborg, P.; Någren, K. 1987: Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease Advances in Neurology 45: 99-101
Quesada, J.L.; Alcalde, J.M.; García-Velloso, M.J.; Cervera-Paz, F.J.; García-Tapia, R. 2000: Positron-emission tomography (PET) in the diagnosis of malignancy, recurrence, and staging in patients with head and neck tumors Acta Otorrinolaringologica Espanola 51(7): 629-633
Seifert, E.; Schadel, A.; Haberkorn, U.; Strauss, L.G. 1992: Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan) Hno 40(3): 90-93